Tulsa Medical Laboratory

Tulsa Medical Laboratory is pleased to announce that we will offer Cervista™ HPV HR from Hologic™---the makers of the ThinPrep® Pap test starting
March 1, 2010. Cervista™ HPV HR is a highly accurate screening test for 14 high-risk human papillomavirus (HPV) types associated with cervical cancer.

Now you can offer your patients a high-risk HPV screening test that provides new levels of efficiency and responsiveness, including:

99.1% Negative Predictive Value (NPV) for CIN2+
No cross-reactivity with common low-risk HPV types

An internal control to assess both sample cellularity and contamination
Requires only 2ml of specimen, limiting the QNS cases
Improved turn-around time
HPV 16/18 genotyping for positive Cervista™ HPV HR results

Genotyping for HPV types 16 and 18 as an adjunct to Cervista™ HPV HR screening and Pap testing allows for more efficient triage of patients. The Cervista™ HPV HR 16/18 uses the residual extracted DNA from the specimen limiting the Quantity Not Sufficient results.

Tulsa Medical Lab is committed to providing the highest quality tests. If you have any questions, please feel free to call:

Sincerely,
Greg Williams, MD
Director of Cytology

The new Cellient™ Automated Cell Block System - the first fully automated cell blocking system built on ThinPrep® technology. Improves capture by maximizing cellularity even from small/scanty samples. Improves presentation by maintaining crisp, clear cellular architectural detail with concentrations of cells within the block. Allows for review of cytology and cell block simultaneously. Improves consistency by being fully automated with minimal operator dependency. Less cross-contamination risk along with consistently rapid processing time (45 minutes or less).

Gen-Probe Aptima Combo 2 Assay, FDA-approved Nucleic Acid Amplification Test (NAATs) for CT/NG testing for dual Chlamydia trachomatis and Neisseria gonorrhea testing (NAATs are the most sensitive and specific tests currently available). FDA-approved for the most collection sites available for CT/NG testing. Sites include male/female swabs, male/female urines and ThinPrep Pap Test vials in symptomatic and asymptomatic individuals. Advantages of the system include FDA approval for urine specimen testing, target amplification of RNA, reduction for potential cross-contamination, the elimination and/or reduction of potential inhibitors and simultaneous detection of Chlamydia and Gonorrhea.

Ask us about our new, easy to use, Encompass Web-Based reporting system. Clinicians and their office staff can now access our web-based reporting system to check on report status and printing options for both Cytology and Tissue reports. No special equipment needed - just access to the internet. For more information or to have your computer workstations set up for Encompass, please contact Regina De Maio at Tulsa Medical Laboratory, 918.481.7854.



©2008 Tulsa Medical Lab. All rights reserved.	6565 S. Yale Ave. Ste. 410	Tulsa, OK 74136	Phone: 918.481.7844	Fax: 918.481.7852